CEBPA point mutations in hematological malignancies (Q34388725)

1 August 2017

1 reference

title

CEBPA point mutations in hematological malignancies (English)

1 reference

1 August 2017

5

Fenaux P

1 reference

1 August 2017

6

Preudhomme C

1 reference

1 August 2017

Leroy H

1

1 reference

1 August 2017

Roumier C

series ordinal

2

1 reference

1 August 2017

Huyghe P

series ordinal

3

1 reference

1 August 2017

Biggio V

series ordinal

4

1 reference

1 August 2017

publication date

1 March 2005

1 reference

1 August 2017

1 reference

1 August 2017

volume

19

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

329-334

1 reference

Disruption of differentiation in human cancer: AML shows the way.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

New mechanisms of AML1 gene alteration in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Induction of granulocytic differentiation by 2 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

c-Myc is a critical target for c/EBPalpha in granulopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Cell cycle inhibition mediated by the outer surface of the C/EBPα basic region is required but not sufficient for granulopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Transcriptional regulation of granulocyte and monocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

C/EBPalpha mutations in acute myeloid leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Prognostically useful gene-expression profiles in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

A dominant-negative mutant of C/EBPalpha, associated with acute myeloid leukemias, inhibits differentiation of myeloid and erythroid progenitors of man but not mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

Translation start site multiplicity of the CCAAT/enhancer binding protein alpha mRNA is dictated by a small 5' open reading frame.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

The transcription factors c-myb and C/EBP alpha regulate the monocytic/myeloic gene MRP14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

7 January 2021

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

7 January 2021

Infrequent hypermethylation of CEBPA promotor in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

7 January 2021

Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403614

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403614

1 reference

Dimensions Publication ID

1 August 2017

1049861833

0 references

1 reference